NKp46+ expression on NK cells as a biomarker for liver pathology and IFN-responiveness in HCV infection

Gut

Volumn 63, Issue 3, 2014, Pages 382-384

  Thimme, Robert ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C; IMMUNE RESPONSE; INTERFERON;

ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; KILLER CELLS, NATURAL; LIVER; MALE; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1;

EID: 84893717267     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-305087     Document Type: Note

References (22)

1. Mondelli MU, Varchetta S, Oliviero B. Natural killer cells in viral hepatitis: facts and controversies. Eur J Clin Invest 2010;40:851-63.
2. Rehermann B. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest 2009;119:1745-54.
3. Thimme R, Binder M, Bartenschlager R. Failure of innate and adaptive immune responses in controlling hepatitis C virus infection. FEMS Microbiol Rev 2012;36:663-83.
4. Jost S, Altfeld M. Control of human viral infections by natural killer cells. Annu Rev Immunol 2013; 31:163-94.
5. Khakoo SI, Thio CL, Martin MP, et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004;305:872-4. (Pubitemid 39038423)
6. Golden-Mason L, Cox AL, Randall JA, et al. Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro. Hepatology 2010;52:1581-9.
7. Werner JM, Heller T, Gordon AM, et al. Innate immune responses in hepatitis C virus exposed healthcare workers who do not develop acute infection. Hepatology Published Online First: 5 Mar 2013. doi: 10.1002/hep.26353
8. Amadei B, Urbani S, Cazaly A, et al. Activation of natural killer cells during acute infection with hepatitis C virus. Gastroenterology 2010;138: 1536-45.
9. Pelletier S, Drouin C, Bedard N, et al. Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses. J Hepatol 2010;53:805-16.
10. Zhu H, Dong H, Eksioglu E, et al. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system. Gastroenterology 2007;133:1649-59. (Pubitemid 350029762)
11. Ahlenstiel G, Edlich B, Hogdal LJ, et al. Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C. Gastroenterology 2011;141:1231-39.
12. Edlich B, Ahlenstiel G, Zabaleta Azpiroz A, et al. Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients. Hepatology 2012;55:39-48.
13. Heeg M, Thimme R. Natural killer cells and hepatitis C: natural killer p46 expression linked to antiviral and antifibrotic activity. Hepatology 2012;56: 1197-200.
14. Kramer B, Korner C, Kebschull M, et al. Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis. Hepatology 2012;56:1201-13.
15. Golden-Mason L, Stone AE, Bambha KM, et al. Race- and gender-related variation in natural killer p46 expression associated with differential anti-hepatitis C virus immunity. Hepatology 2012;56:1214-22.
16. Pembroke T, Christian A, Jones E, et al. The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon alpha treatment. Gut 2014; 63:515-24.
17. Varchetta S, Mele D, Mantovani S, et al. Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection. Hepatology 2012;56:841-9.
18. Pembroke T, Rees I, Gallagher K, et al. Rapid early innate control of hepatitis C virus during IFN-alpha treatment compromises adaptive CD4+ T-cell immunity. Eur J Immunol 2012;42:2383-94.
19. Bozzano F, Picciotto A, Costa P, et al. Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment. Eur J Immunol 2011;41:2905-14.
20. Drenth JP. HCV treatment-no more room for interferonologists? N Engl J Med 2013;368:1931-2.
21. Sarasin-Filipowicz M, Oakeley EJ, Duong FH, et al. Interferon signaling and treatment outcome in chronic hepatitis C. Proc Natl Acad Sci USA 2008;105:7034-9. (Pubitemid 351754525)
22. Abdel-Hakeem MS, Bedard N, Badr G, et al. Comparison of immune restoration in early versus late alpha interferon therapy against hepatitis C virus. J Virol 2010;84:10429-35.